Perspectives in Thoracic Oncology (22nd Annual)

Past participants of this meeting—nearly 200 annually—value the scope and depth of the content presented. Unlike other annual lung conferences which often focuses on only treatment late-stage NSCLC, this conference offers a broader scope of the topics essential for practicing oncologists. Everything from “soup to nuts” is discussed—from lung cancer screening and smoking cessation; to biomarker testing; to management of lung cancer across the spectrum of disease stages and including NSCLC, SCLC, mesothelioma, and other thoracic tumors.

Corey J. Langer, MD, FACP Chair